sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
tcaccaagaatttggcatttcaa | 4416 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcaccaagaatttggcatttcaa | 4416 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcaccaagaatttggcatttcaa | 4416 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcaccaagaatttggcatttcaa | 4416 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
attgctgcctctttccattctgc | 8217 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
attgctgcctctttccattctgc | 8217 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
attgctgcctctttccattctgc | 8217 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
attgctgcctctttccattctgc | 8217 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagactccacttcagcctacagc | 8090 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagactccacttcagcctacagc | 8090 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagactccacttcagcctacagc | 8090 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagactccacttcagcctacagc | 8090 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagatgtcaagaattattttgac | 1664 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tagatgtcaagaattattttgac | 1664 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tagatgtcaagaattattttgac | 1126 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagatgtcaagaattattttgac | 1126 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagatgtcaagaattattttgac | 1126 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagatgtcaagaattattttgac | 1126 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagatgtcaagaattattttgac | 1664 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tagatgtcaagaattattttgac | 1664 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcggctgtgacatgggcacctgc | 3076 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcggctgtgacatgggcacctgc | 3076 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcggctgtgacatgggcacctgc | 3076 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcggctgtgacatgggcacctgc | 3076 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcgagacattccttatcacaat | 4327 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcgagacattccttatcacaat | 4327 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcgagacattccttatcacaat | 4327 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atcgagacattccttatcacaat | 4327 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaaacaacttaaaattgctt | 1943 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaaacaacttaaaattgctt | 1943 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaaacaacttaaaattgctt | 1943 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagtaaacaacttaaaattgctt | 1943 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 3942 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 3942 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 4751 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 4751 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 3942 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
cagagaacagatgattcttta | 3942 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
cagagaacagatgattcttta | 3404 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 3404 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 3404 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 3404 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cagagaacagatgattcttta | 4751 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
cagagaacagatgattcttta | 4751 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
tttcccaggcacagggcatctgt | 8346 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcccaggcacagggcatctgt | 8346 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcccaggcacagggcatctgt | 8346 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tttcccaggcacagggcatctgt | 8346 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 3804 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 3804 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 4613 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gatttctgagaacaagtaaaa | 4613 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gatttctgagaacaagtaaaa | 3266 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 3266 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 3804 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gatttctgagaacaagtaaaa | 3804 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gatttctgagaacaagtaaaa | 4613 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 4613 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 3266 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatttctgagaacaagtaaaa | 3266 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tggaattatagagtgacttggga | 1626 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tggaattatagagtgacttggga | 1626 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tggaattatagagtgacttggga | 1088 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tggaattatagagtgacttggga | 1088 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tggaattatagagtgacttggga | 1626 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tggaattatagagtgacttggga | 1626 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tggaattatagagtgacttggga | 1088 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tggaattatagagtgacttggga | 1088 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 448 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tacgtagacttccaggaactt | 448 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tacgtagacttccaggaactt | 448 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 448 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 6817 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tacgtagacttccaggaactt | 6817 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tacgtagacttccaggaactt | 178 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 178 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 178 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 178 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 6817 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tacgtagacttccaggaactt | 6817 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cacctgcagctgtgctgggcatg | 3084 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cacctgcagctgtgctgggcatg | 3084 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cacctgcagctgtgctgggcatg | 3084 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cacctgcagctgtgctgggcatg | 3084 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 3369 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 3369 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 3907 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctgatggtagaattaaccata | 3907 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctgatggtagaattaaccata | 4716 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 4716 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 4716 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctgatggtagaattaaccata | 4716 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
ctgatggtagaattaaccata | 3907 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 3907 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 3369 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgatggtagaattaaccata | 3369 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tctttacaggcaaagtcagtaat | 1758 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tctttacaggcaaagtcagtaat | 1758 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tctttacaggcaaagtcagtaat | 1758 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tctttacaggcaaagtcagtaat | 1758 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.